Veracyte at ISLB 2026
Nov 7–9, 2026 Madrid, Spain ~700 attendees Website
Veracyte brings 2 presentations to ISLB 2026 in Madrid, and exhibits at Booth 17. Its work centres on whole-genome approaches to tracking minimal residual disease (MRD) through circulating tumour DNA. It covers its TrueMRD platform and the studies in its pipeline.
| Organization | ISLB 2026 Attendance |
|---|---|
Veracyte South San Francisco, CA | ◇Bronze Sponsor |
Diagnostics company whose tests give clinicians insights to guide cancer diagnosis and treatment decisions. | Booth Exhibiting at Booth 17 Sat, Nov 710:00am–4:00pm, 6:00–7:30pmSun, Nov 810:00am–4:00pmMon, Nov 98:30am–10:30am Industry Mon Nov 9 9:00am–10:00am Industry Mon Nov 9 9:00am–10:00am Industry Mon Nov 9 9:00am–10:00am |
Instantly find 20 buyers from Veracyte
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction